13 Oct
Managing Cardiovascular Risk in Minority Patients: LIPID-LOWERING TREATMENT
LIPID-LOWERING TREATMENT IN MINORITY GROUPS: EVIDENCE TO DATE Clinical trial evidence supports the treatment recommendations of the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) in white patients, but minority patients have been under-represented in the major statin trials. There is no reason to believe that statins are not equally effective in [...]